Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
5.36M
-
Shares change
-
-59K
-
Total reported value, excl. options
-
$7.29M
-
Value change
-
-$137K
-
Put/Call ratio
-
0.31
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$1.36
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2022
35 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2022.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.36M shares
of 104M outstanding shares and own 5.17% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3.26M shares), VANGUARD GROUP INC (503K shares), MORGAN STANLEY (378K shares), GEODE CAPITAL MANAGEMENT, LLC (288K shares), Bank Julius Baer & Co. Ltd, Zurich (148K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (126K shares), STATE STREET CORP (115K shares), CITADEL ADVISORS LLC (104K shares), Cowen Prime Advisors LLC (96.6K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (74.7K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.